You are here: Industry Insights > AVATAMED

News List

AVATAMED sets up Joint Service Lab with A*STAR's Institute of Molecular and Cell Biology to offer Precision Oncology Services prnasia
June 01, 2021
AVATAMED, a precision medicine service company based in Singapore, announced the setting up of a joint lab with Singapore's Institute of Molecular and Cell Biology (IMCB) at the Agency for Science, Technology and Research (A*STAR), to offer precision ...
AVATAMED and Macrogen sign MOU on joint business in personalized precision medicine services in cancer treatment prnasia
October 30, 2020
AVATAMED, a precision medicine service company based in Singapore, represented by CEO Mr. Hong Boon Toh, has entered into a business agreement on 29 October 2020 with Macrogen, a biotechnology company in precision medicine headquartered in South Korea ...
AVATAMED Partners CBmed in Europe on Precision Cancer Project prnasia
July 13, 2020
AVATAMED and CBmed, together with AIMEDBIO and Shimadzu Corporation, are collaborating in a Precision Cancer Project, leveraging on a new technology in cancer research.